Journal of the Society for Gynecologic Investigation

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

http://mc.manuscriptcentral.com/rsci

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, E. A.
Right arrow Articles by Nowak, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, E. A.
Right arrow Articles by Rhoades, A. R.
Right arrow Articles by Nowak, R. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of the Society for Gynecologic Investigation, Vol. 5, No. 1, 44-47 (1998)
DOI: 10.1177/107155769800500109

Leuprolide Acetate-Treated Leiomyomas Retain Their Relative Overexpression of Collagen Type I and Collagen Type III Messenger Ribonucleic Acid

Elizabeth A. Stewart, MD

Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School and Brigham and Women's Hospital, Boston. Massachusetts; Laboratory for Human Reproduction and Reproductive Biology, Room 449, Boston Lying In, 221 Logwood Avenue, Boston, MA 02115. eastewart{at}bics.bwh.harvard.edu

Alan R. Rhoades, BS

Romana A. Nowak, PhD

Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School and Brigham and Women's Hospital, Boston. Massachusetts

Objective: To evaluate the levels of mRNA for the extracellular matrix proteins collagen type I, collagen type III, and fibronectin in leiomyomas and myometrium obtained from women treated with GnRH-agonist (GnRH-a) and to examine steroid hormone regulation of these proteins using an in vitro explant culture system.

Methods: Northern blot analysis of mRNA was obtained from hysterectomy specimens at the time of surgery or after 48 hours of in vitro steroid treatment. A portion of the tissue was processed for RNA, and the remaining tissue was used to establish explant cultures. Extracellular matrix/{alpha}-tubulin ratio was computed for each band, and within each experiment the lowest ratio was standardized to a value of one denstometry unit to allow for comparison among experiments.

Results: There is a relative overeexpression of both collagen type I and collagen type III mRNAs but not fibronectin in leiomyomas compared to myometrium from the same uteri of women treated with GnRH-a.

Conclusion: Leiomyomas obtained from women treated with GnRH-a show an up-regulation of collagens type I and type III similar to that seen in leiomyomas obtained from women in the proliferative phase of their menstrual cycles.

Key Words: Leiomyomas • myometrium • collagen • gonadotropin-releasing hormone agonist


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?